Skip to Content

Dolizem Approval Status

FDA Approved: No
Brand name: Dolizem
Generic name: diltiazem hydrochloride
Dosage form: Topical Cream
Company: Ventrus Biosciences
Treatment for: Anal Fissure and Fistula

Dolizem (diltiazem) is an investigational topical calcium-channel blocker applied perianally to treat pain related to anal fissure.

Development Status and FDA Approval Process for Dolizem

DateArticle
Apr  4, 2014Ventrus Biosciences Receives Date for Type B Pre-NDA Meeting With FDA for Dolizem
Feb 12, 2014Ventrus Biosciences Announces Results From Second Pivotal Phase 3 Trial of Diltiazem Cream (VEN 307) in Patients With Anal Fissure
May 14, 2012Ventrus Biosciences Announces Positive Results From Pivotal Phase 3 Trial of Diltiazem (VEN 307) in Patients With Anal Fissures

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide